Results 251 to 260 of about 1,254,005 (293)
Some of the next articles are maybe not open access.
[Genetic markers of viral vaccines].
Annali Sclavo; rivista di microbiologia e di immunologia, 1981This paper deals with virus vaccines and their genetic markers. In particular we have examined four of the attenuated virus vaccines, now in widespread use, prepared in cell cultures, i.e. poliomyelitis, measles, mumps and rubella. The data reported could be of critical value for the evaluation of the safety and the prophylactic activity of the ...
openaire +1 more source
Immunological Markers of Cancer Vaccine Efficacy and their Clinical Relevance
Biomarkers in Medicine, 2009As the field of anticancer therapy advances, with a mission to either prevent tumors or improve the quality of life and survival of those affected by the disease, biomarker discovery in oncology is also growing. Since cancer therapy has become a type of personalized medicine, biomarkers are strongly needed in order to identify the right therapy for the
openaire +2 more sources
Overview of marker vaccine and differential diagnostic test technology
Biologicals, 2005Recent advances in molecular biology, immunology, microbiology, genetics and microbial pathogenesis have lead to the development of a wide variety of new approaches for developing safer and more effective vaccines based on designs such as subunit vaccines, gene deleted vaccines, live vectored vaccines, and DNA mediated vaccines. Technology tools can be
openaire +2 more sources
Why Young Patients With Cancer Refuse the Human Papillomavirus Vaccine
Ca-A Cancer Journal for Clinicians, 2023Mike Fillon
exaly
Marker vaccines and the impact of their use on diagnosis and prophylactic measures.
Revue scientifique et technique (International Office of Epizootics), 2007Molecular biology and technical advances in DNA recombination have ushered in a new era in vaccinology. This article examines the recent development of specific marker vaccines and examines the impact of their use on the diagnosis and prevention of major infectious diseases.
Vannier, P. +7 more
openaire +2 more sources
Vaccine Therapy for Malignant Melanoma
Ca-A Cancer Journal for Clinicians, 1996D L Morton, Donald L Morton
exaly
Vaccine Trials for Osteogenic Sarcoma: A Preliminary Report
Ca-A Cancer Journal for Clinicians, 1973Andrew G Huvos +2 more
exaly

